Stroke is the predominant factor of long-term impairment in developed nations and is a
major contributor to death globally. Stroke is a life-threatening neurological condition caused …

Edaravone, a pyrazalone derivative, is an antioxidant and free radical scavenger used to
treat oxidative stress-related diseases. It is a proven drug to mitigate conditions prevailing to …

Acute ischemic stroke (AIS) is associated with a high mortality rate and poor prognosis, with
a lack of effective therapeutic drugs for post-thrombolytic treatment. MicroRNA-based gene …

We conducted a post hoc analysis of Remote Ischemic Conditioning for Acute Moderate
Ischemic Stroke (RICAMIS) to investigate whether red blood cell (RBC) indices are …

Therapies to improve outcomes after ischaemic stroke are currently exclusively based on
successful thrombolysis or thrombectomy. However, despite significant progress to extend …

In this systematic review, we aim to clarify common findings on carbenoxolone's effects on
neurological conditions, including stroke, across studies and identify areas where …

Stroke, a major cerebrovascular disease, has high morbidity and mortality. Effective methods
to reduce the risk and improve the prognosis are lacking. Currently, uric acid (UA) is …

Ischemic stroke (IS) is a globally life-threatening disease. Presently, few therapeutic
medicines are available for treating IS, and rt-PA is the only drug approved by the US Food …

The role of the cerebellum in anoxic–irschemic brain damage and neurological clinical trials
Page 1 Brain and Spine 4 (2024) 102865 Available online 10 July 2024 2772-5294/© 2024 …

Background Evidence supports Cerebrolysin's efficacy in reducing hemorrhagic
transformation (HT), but its impact on the timing of resuming anticoagulation therapy in …